Armistice Capital LLC Makes New $619,000 Investment in The Clorox Company (NYSE:CLX)

Armistice Capital LLC acquired a new position in shares of The Clorox Company (NYSE:CLX) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,538 shares of the company’s stock, valued at approximately $619,000.

Several other hedge funds also recently modified their holdings of CLX. GoalVest Advisory LLC bought a new stake in Clorox in the first quarter valued at $31,000. First Foundation Advisors acquired a new stake in shares of Clorox in the 1st quarter valued at about $31,000. Core Wealth Advisors Inc. bought a new stake in Clorox in the 4th quarter valued at about $29,000. Innealta Capital LLC acquired a new position in Clorox during the 2nd quarter worth approximately $30,000. Finally, Trifecta Capital Advisors LLC boosted its holdings in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.51% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. DA Davidson restated a “neutral” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Argus upgraded shares of Clorox to a “hold” rating in a report on Tuesday, June 4th. Citigroup upped their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, Barclays lifted their price target on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. Six equities research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $143.33.

Clorox Trading Down 0.7 %

Shares of Clorox stock opened at $161.91 on Friday. The stock has a fifty day moving average price of $150.84 and a 200-day moving average price of $143.96. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The firm has a market cap of $20.11 billion, a PE ratio of 83.89, a P/E/G ratio of 3.31 and a beta of 0.40. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. Equities research analysts anticipate that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.01%. Clorox’s dividend payout ratio is presently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.